Le Lézard
Classified in: Health
Subject: PDT

Lung Health Institute Gives Patients Hope for a Better Future


TAMPA, Fla., Aug. 16, 2018 /PRNewswire/ -- Armed with expanded services and a new, comprehensive approach to treating the third leading cause of death in the United States, Lung Health Institute is helping pave the way forward for the millions of Americans suffering from chronic lung disease.

Lung Health Institute Logo

"Chronic lung disease has plagued our society for years and every day, our team sees firsthand the impact it has on the patients we treat," Jimmy St. Louis, CEO of Lung Health Institute, formerly known as Lung Institute, said. "We recognize that so much more needs to be done to advance the way chronic lung disease is treated and that's why we continually evolve to meet the growing needs of our patients."

Since 1980, more than 4.6 million Americans have died from chronic respiratory disease, according to a recent study published in the Journal of the American Medical Association, which equates to an increase of nearly 31 percent in the span of a few decades.

"For too long, people suffering from chronic lung disease have been left behind," Jack Coleman, M.D., Lung Health Institute, said. "At Lung Health Institute, we look to bridge the gap between what's available in terms of treatment for lung disease currently and what's possible in the future."

In addition to introducing new programs such as the Anti-Inflammatory Initiative (AI2) designed to increase lung function by reducing systemic inflammation, the Lung Health Institute created an advisory board to guide research efforts aimed at accelerating the advancement of chronic lung disease treatment.

"We're challenging ourselves to push beyond conventional treatment to give lung disease patients hope for a better future and we're always in search of the next breakthrough that will revolutionize care," Dr. Coleman said. "All of our resources are being focused on slowing the progression of lung disease and improving the quality of life for those affected by lung disease."

For more information about Lung Health Institute's work to solidify the path forward as treatment options for lung disease evolve, visit thelunghealthinstitute.com.

About Lung Health Institute

Lung Health Institute leads the industry in regenerative medicine and is among the first cellular therapy providers accredited by The Joint Commission, widely considered the gold standard of quality patient care. Our exclusive focus on and multidisciplinary approach to lung disease yields expert care for every patient, even when conventional treatment isn't effective or stops working. Offering a variety of programs and services including the Anti-Inflammatory Initiative and cellular therapy in several locations across the United States, Lung Health Institute has helped thousands of people with chronic lung disease improve their quality of life and Breathe Easiertm. For more information, visit thelunghealthinstitute.com.

SOURCE Lung Health Institute


These press releases may also interest you

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...

at 16:42
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...



News published on and distributed by: